Literature DB >> 21115737

Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.

Sabrina B Taner1, Marcelo J Pando, Allison Roberts, Jennifer Schellekens, Steven G E Marsh, Karl-Johan Malmberg, Peter Parham, Frances M Brodsky.   

Abstract

Variable interaction between the <span class="Gene">Bw4 epitope of HLA-B and the polymorphic KIR3DL1/S1 system of inhibitory and activating NK cell receptors diversifies the development, repertoire formation, and response of human NK cells. KIR3DL1*004, a common KIR3DL1 allotype, in combination with Bw4(+) HLA-B, slows progression of HIV infection to AIDS. Analysis in this study of KIR3DL1*004 membrane traffic in NK cells shows this allotype is largely misfolded but stably retained in the endoplasmic reticulum, where it binds to the chaperone calreticulin and does not induce the unfolded protein response. A small fraction of KIR3DL1*004 folds correctly and leaves the endoplasmic reticulum to be expressed on the surface of primary NK and transfected NKL cells, in a form that can be triggered to inhibit NK cell activation and secretion of IFN-γ. Consistent with this small proportion of correctly folded molecules, trace amounts of MHC class I coimmunoprecipitated with KIR3DL1*004. There was no indication of any extensive intracellular interaction between unfolded KIR3DL1*004 and cognate Bw4(+) HLA-B. A similarly limited interaction of Bw4 with KIR3DL1*002, when both were expressed by the same cell, was observed despite the efficient folding of KIR3DL1*002 and its abundance on the NK cell surface. Several positions of polymorphism modulate KIR3DL1 abundance at the cell surface, differences that do not necessarily correlate with the potency of allotype function. In this context, our results suggest the possibility that the effect of Bw4(+) HLA-B and KIR3DL1*004 in slowing progression to AIDS is mediated by interaction of Bw4(+) HLA-B with the small fraction of cell surface KIR3DL1*004.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115737      PMCID: PMC3129036          DOI: 10.4049/jimmunol.0903657

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

1.  The size of the synaptic cleft and distinct distributions of filamentous actin, ezrin, CD43, and CD45 at activating and inhibitory human NK cell immune synapses.

Authors:  Fiona E McCann; Bruno Vanherberghen; Konstantina Eleme; Leo M Carlin; Ray J Newsam; David Goulding; Daniel M Davis
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

2.  Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains.

Authors:  S Rojo; N Wagtmann; E O Long
Journal:  Eur J Immunol       Date:  1997-02       Impact factor: 5.532

3.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

4.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Interactions of Ly49 family receptors with MHC class I ligands in trans and cis.

Authors:  Léonardo Scarpellino; Franziska Oeschger; Philippe Guillaume; Jérôme D Coudert; Frédéric Lévy; Georges Leclercq; Werner Held
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

7.  A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages.

Authors:  Malinda R Schaefer; Maya Williams; Deanna A Kulpa; Pennelope K Blakely; Anna Q Yaffee; Kathleen L Collins
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

8.  Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.

Authors:  Deepti Sharma; Karine Bastard; Lisbeth A Guethlein; Paul J Norman; Nobuyo Yawata; Makoto Yawata; Marcelo Pando; Hathairat Thananchai; Tao Dong; Sarah Rowland-Jones; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.

Authors:  M J Robertson; K J Cochran; C Cameron; J M Le; R Tantravahi; J Ritz
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

10.  Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule.

Authors:  C J VandenBussche; T J Mulrooney; W R Frazier; S Dakshanamurthy; C K Hurley
Journal:  Genes Immun       Date:  2008-11-13       Impact factor: 2.676

View more
  24 in total

1.  Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages.

Authors:  Alexandre Esteban; Maximilian W Popp; Valmik K Vyas; Karin Strijbis; Hidde L Ploegh; Gerald R Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

3.  Association of variably expressed KIR3dl1 alleles with psoriatic disease.

Authors:  Jeffrey Berinstein; Remy Pollock; Fawnda Pellett; Arane Thavaneswaran; Vinod Chandran; Dafna D Gladman
Journal:  Clin Rheumatol       Date:  2017-08-11       Impact factor: 2.980

4.  KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding.

Authors:  Tiernan J Mulrooney; Aaron C Zhang; Yehuda Goldgur; Jeanette E Boudreau; Katharine C Hsu
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

5.  A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule.

Authors:  Ana Goyos; Lisbeth A Guethlein; Amir Horowitz; Hugo G Hilton; Michael Gleimer; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

6.  KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

Authors:  Jeanette E Boudreau; Fabio Giglio; Ted A Gooley; Philip A Stevenson; Jean-Benoît Le Luduec; Brian C Shaffer; Raja Rajalingam; Lihua Hou; Carolyn Katovich Hurley; Harriet Noreen; Elaine F Reed; Neng Yu; Cynthia Vierra-Green; Michael Haagenson; Mari Malkki; Effie W Petersdorf; Stephen Spellman; Katharine C Hsu
Journal:  J Clin Oncol       Date:  2017-05-18       Impact factor: 44.544

7.  Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Authors:  Michael A Eller; Rebecca N Koehler; Gustavo H Kijak; Leigh Anne Eller; David Guwatudde; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

Review 8.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

9.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

10.  KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.

Authors:  Christopher J Forlenza; Jeanette E Boudreau; Junting Zheng; Jean-Benoît Le Luduec; Elizabeth Chamberlain; Glenn Heller; Nai-Kong V Cheung; Katharine C Hsu
Journal:  J Clin Oncol       Date:  2016-04-11       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.